Gapping down
In reaction to earnings/guidance:
- D -3% (guidance), NKE -2.9%, BRCC -2.7% (guides Q2 revs below consensus; also CFO and COO to step down), STZ -0.8%
Other news:
- ROOT -18.3% (says it is not in receipt of any proposal that is actionable or in best interests of its shareholders)
- TRUP -8.2% (weakness attributed to cautious research report)
- CRMT -5.3% (files $400 mln mixed shelf securities offering)
- TRVI -3.1% (files $200 mln mixed shelf securities offering)
- PTCT -3% (MIT-E trial fails to achieve primary endpoint)
- DRIO -3% (files for 6583890 shares of common stock by selling shareholders)
- FARO -2.3% (names new CEO)
- BLCO -2.2% (will pay $1.75 bln for eye drug from Novartis (NVS) according to WSJ)
Analyst comments:
- CLB -3.4% (downgraded to Sell from Neutral at Citigroup)